» Articles » PMID: 22833182

Myocardial Infarction Changes Sphingolipid Metabolism in the Uninfarcted Ventricular Wall of the Rat

Overview
Journal Lipids
Specialty Biochemistry
Date 2012 Jul 27
PMID 22833182
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

It is known that the ratio, the level of sphingosine-1-phosphate (S1P)/the level of ceramide (CER) determines survival of the cells. The aim of the present study was to examine the effect of myocardial infarction on the level of different sphingolipids in the uninfarcted area. The experiments were carried out on male Wistar rats: 1, control; 2, after ligation of the left coronary artery (infarct) and 3, sham operated. Samples of the uninfarcted area of the left ventricle were taken in 1, 6 and 24 h after the surgery. The level of sphingolipids, S1P, CER, sphingosine (SPH), sphinganine-1-phosphate (SPA1P) and sphinganine (SPA) was determined. The control values were (ng/mg), S1P-0.33 ± 0.03, SPH-1.02 ± 0.13, SPA1P-0.11 ± 0.01, SPA-0.28 ± 0.04, total CER-20.3 ± 1.8. In infarct, the level of S1P in the uninfarcted area was reduced by ~3 times in 1 and 6 h and decreased further in 24 h. The level of SPH decreased in 1 h and returned to the control thereafter. The total level of CER decreased in 6 h after the infarction. Sham surgery also produced changes in the level of certain sphingolipids. The ratio, the level of S1P/the level of CER was markedly reduced at each time point after the infarction. It is concluded that the reduction in the S1P/CER ratio could be responsible for increased apoptosis in the uninfarcted area after the myocardial infarction in the rat.

Citing Articles

Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease.

Gaggini M, Fenizia S, Vassalle C Antioxidants (Basel). 2023; 12(5).

PMID: 37237968 PMC: 10215120. DOI: 10.3390/antiox12051102.


Screening of sphingolipid metabolism-related genes associated with immune cells in myocardial infarction: a bioinformatics analysis.

Wang J, Wang P, Wang W, Jin H J Thorac Dis. 2022; 14(8):2987-2996.

PMID: 36071762 PMC: 9442515. DOI: 10.21037/jtd-22-1041.


Implication of Sphingolipid Metabolism Gene Dysregulation and Cardiac Sphingosine-1-Phosphate Accumulation in Heart Failure.

Perez-Carrillo L, Gimenez-Escamilla I, Martinez-Dolz L, Sanchez-Lazaro I, Portoles M, Rosello-Lleti E Biomedicines. 2022; 10(1).

PMID: 35052814 PMC: 8773611. DOI: 10.3390/biomedicines10010135.


Cardiac phospholipidome is altered during ischemia and reperfusion in an ex vivo rat model.

Montero-Bullon J, Aveiro S, Melo T, Martins-Marques T, Lopes D, Neves B Biochem Biophys Rep. 2021; 27:101037.

PMID: 34169155 PMC: 8207217. DOI: 10.1016/j.bbrep.2021.101037.


Identification of Novel miRNAs Involved in Cardiac Repair Following Infarction in Fetal and Adolescent Sheep Hearts.

Lock M, Tellam R, Darby J, Soo J, Brooks D, Seed M Front Physiol. 2020; 11:614.

PMID: 32587529 PMC: 7298149. DOI: 10.3389/fphys.2020.00614.


References
1.
Kennedy S, Kane K, Pyne N, Pyne S . Targeting sphingosine-1-phosphate signalling for cardioprotection. Curr Opin Pharmacol. 2008; 9(2):194-201. DOI: 10.1016/j.coph.2008.11.002. View

2.
Zhang D, Fryer R, Hsu A, Zou A, Gross G, Campbell W . Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats. Basic Res Cardiol. 2001; 96(3):267-74. DOI: 10.1007/s003950170057. View

3.
Baranowski M, Zabielski P, Blachnio A, Gorski J . Effect of exercise duration on ceramide metabolism in the rat heart. Acta Physiol (Oxf). 2007; 192(4):519-29. DOI: 10.1111/j.1748-1716.2007.01755.x. View

4.
Karliner J . Sphingosine kinase and sphingosine 1-phosphate in cardioprotection. J Cardiovasc Pharmacol. 2009; 53(3):189-97. PMC: 2835544. DOI: 10.1097/FJC.0b013e3181926706. View

5.
Cordis G, Yoshida T, Das D . HPTLC analysis of sphingomylein, ceramide and sphingosine in ischemic/reperfused rat heart. J Pharm Biomed Anal. 1998; 16(7):1189-93. DOI: 10.1016/s0731-7085(97)00260-4. View